Individuals with chronic vs episodic migraine may be more likely to experience chronic back pain, chronic pain, neck pain, anxiety, and depression.
Mental disorders are positively associated with subsequent self-reported chronic back and/or neck pain, with a clear dose-response relationship between the number of mental disorders and subsequent pain.
A large proportion of patients with episodic migraine have greater risk for cardiovascular disease with increasing age and subsequently have contraindications to treatment with triptan and ergot medications.
Patients with chronic depression and comorbid panic disorder are more likely to experience side effects as a result of treatment with antidepressant medications.
Pain is more common in those with depression and those with both depression and pain are more likely to have cognitive impairment.
Adequate diagnosis and treatment of anxiety and depression needed for improved management of tension-type headaches.
A Pain-Related Beliefs and Attitudes about Sleep scale assesses attitudes about sleep among individuals with chronic pain.
Genetic factors and the environment patients share with their partner or spouse may determine their risk of developing chronic pain and help explain the association between chronic pain and depression.
The Short-Form Health Survey as an Effective Diagnostic Tool for Psychiatric Comorbidities in RA PatientsAugust 02, 2016
The analysis found that the SF-36 survey was an effective diagnostic tool for MDD and GAD in patients with RA.
Individuals experiencing chronic pain in adolescence are more likely to develop anxiety and depressive disorders in adulthood.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Predicting Pain Chronicization After Spine Surgery
- Chronic Low Back Pain Levels Vary Between Sex and Race
- FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?
- Errors in Clinical Notes Generated by Speech Recognition Are Not Uncommon
- Effectiveness of Medication for Opioid Use Disorder on Mortality After Overdose Reviewed Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?